Kalbe Farma (Indonesia) provided earnings guidance for the full year 2015. The company expected its full-year 2015 sales to grow 2%-3% year on year and its net profit to fall by 3%-4% year on year, amid slowing macroeconomic conditions.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
1,560 IDR | +3.65% | +4.00% | -3.11% |
05-17 | Nomura Adjusts Kalbe Farma’s Price Target to 1,900 Rupiahs From 1,850 Rupiahs, Keeps at Buy | MT |
04-30 | PT Kalbe Farma Tbk. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-3.11% | 4.51B | |
+38.51% | 727B | |
+33.05% | 599B | |
-6.23% | 354B | |
+18.78% | 328B | |
+1.35% | 277B | |
+16.00% | 243B | |
+8.09% | 205B | |
-5.77% | 203B | |
+6.19% | 164B |
- Stock Market
- Equities
- KLBF Stock
- News PT Kalbe Farma Tbk.
- Kalbe Farma Provides Earnings Guidance for the Full Year 2015